Cargando…
Fam20C Overexpression Predicts Poor Outcomes and is a Diagnostic Biomarker in Lower-Grade Glioma
Glioma is a relatively low aggressive brain tumor. Although the median survival time of patients for lower-grade glioma (LGG) was longer than that of patients for glioblastoma, the overall survival was still short. Therefore, it is urgent to find out more effective molecular prognostic markers. The...
Autores principales: | Feng, Jing, Zhou, Jinping, Zhao, Lin, Wang, Xinpeng, Ma, Danyu, Xu, Baoqing, Xie, Feilai, Qi, Xingfeng, Chen, Gang, Zhao, Hu, Wu, Junxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712682/ https://www.ncbi.nlm.nih.gov/pubmed/34970298 http://dx.doi.org/10.3389/fgene.2021.757014 |
Ejemplares similares
-
High Expression of PLAGL2 is Associated With Poor Prognosis in High-Grade Glioma
por: Wang, Gang, et al.
Publicado: (2022) -
Multi-Omics Analysis Based on Genomic Instability for Prognostic Prediction in Lower-Grade Glioma
por: Cao, Yudong, et al.
Publicado: (2022) -
Identification of a Tumor Microenvironment-Related Eight-Gene Signature for Predicting Prognosis in Lower-Grade Gliomas
por: Su, Jun, et al.
Publicado: (2019) -
Prognostic Model and Nomogram Construction Based on a Novel Ferroptosis-Related Gene Signature in Lower-Grade Glioma
por: Zhao, Junsheng, et al.
Publicado: (2021) -
Prognostic Value of a Stemness Index-Associated Signature in Primary Lower-Grade Glioma
por: Zhang, Mingwei, et al.
Publicado: (2020)